JPMorgan analyst Robbie Marcus reiterated an Overweight rating on Boston Scientific (NYSE: BSX)The analyst comments "Management kicked off the Boston ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE